查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1866592

头孢曲松钠：全球市场份额和排名、总收入和需求预测（2025-2031 年）

Ceftriaxone Sodium - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 114 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年全球头孢曲松钠市场规模预计为 2.5 亿美元，预计到 2031 年将萎缩至 2.07 亿美元，2025 年至 2031 年的复合年增长率为 -2.7%。

本报告对近期关税调整和国际战略反制措施对头孢曲松钠跨境产业布局、资本配置模式、区域经济相互依存关係和供应链重组的影响进行了全面评估。

头孢曲松钠是一种频谱第三代头孢菌素类抗生素，其杀菌作用机转是透过抑制细菌细胞壁合成。它用于治疗呼吸道感染疾病、泌尿系统感染疾病、皮肤和软组织感染疾病、败血症和脑膜炎。由于其半衰期长、作用持久、耐受性好，且可静脉注射或肌肉注射，因此在临床上已广泛应用。近年来，随着抗生素抗药性的增加和全球感染疾病负担的持续加重，医院、社区卫生机构和紧急感染控制领域对头孢曲松钠的需求稳步增长。生产商正在优化生产流程并整合原材料，以提高效率和产品品质的稳定性。本报告分析了头孢曲松钠活性原料药。预计2024年全球产量约2,766吨，平均市场价格约为每公斤94美元。

全球感染疾病负担持续加重，尤其是在开发中国家和人口老化地区，这推动了抗生素需求的稳定增长，并为头孢曲松钠市场提供了强劲的驱动力。世界各国政府正在实施相关政策，以促进抗生素的合理使用、扩大医疗覆盖范围并更新临床指南，鼓励医院购买高品质的抗生素。根据主要製药企业的年度报告，他们持续投资于原料整合、产能扩张和新製剂研发，以确保供应稳定和产品多样化。一份券商报告指出，抗菌素抗药性应对措施、社区感染控制和标准化临床应用的发展趋势将进一步推动头孢曲松钠在医院和基层医疗机构的市场渗透。

头孢曲松钠产业面临许多挑战，例如原料价格波动、生产流程复杂以及严格的国际品质标准。年度报告显示，部分关键原料依赖进口，供应链波动可能影响生产稳定性。抗生素抗药性问题、监管力度加大、集中采购、价格上限等因素可能对中价格分布产品的利润率构成压力。此外，拓展跨境市场需要企业遵守註册核准、市场进入以及应对监管差异，这增加了企业的营运风险。

来自医院、社区健康组织和公共卫生部门的下游需求呈现稳定成长，并伴随着结构优化。临床医师倾向于选择保质期长、给药方案灵活且可静脉注射或肌肉注射的製剂，以便治疗多种感染疾病类型和应对紧急情况。据仲介报告显示，推广抗菌药物管理、医院用药标准化以及引入数位化药物管理系统有望提高头孢曲松钠的临床依从性和库存效率，而高附加价值製剂和新型缓释性产品可能成为未来市场差异化的关键。

本报告旨在按地区/国家、类型和应用对全球头孢曲松钠市场进行全面分析，重点关注总销售量、收入、价格、市场份额和主要企业的排名。

本报告以销售量（吨）和收入（百万美元）为单位，提供头孢曲松钠市场规模、估计值和预测，基准年为2024年，并包含2020年至2031年的历史数据和预测数据。报告采用定量和定性分析相结合的方法，帮助读者制定头孢曲松钠的业务和成长策略，评估市场竞争，分析自身在当前市场中的地位，并做出明智的商业决策。

市场区隔

公司

  • Shandong Ruiying
  • Qilu Antibiotics
  • Nectar Lifesciences
  • Kelun
  • United Laboratories
  • Aurobindo Pharma
  • Orchid Pharma
  • Medya Pharma
  • REYOUNG
  • LKPC
  • ACS Dobfar
  • NCPC
  • Dawnrays
  • Kopran

按类型分類的细分市场

  • ChP
  • USP
  • EP

应用领域

  • 单次注射
  • 复合注射

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Ceftriaxone Sodium was estimated to be worth US$ 250 million in 2024 and is forecast to a readjusted size of US$ 207 million by 2031 with a CAGR of -2.7% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Ceftriaxone Sodium cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Ceftriaxone Sodium is a broad-spectrum third-generation cephalosporin antibiotic that exerts bactericidal effects by inhibiting bacterial cell wall synthesis. It is indicated for the treatment of respiratory tract infections, urinary and reproductive system infections, skin and soft tissue infections, sepsis, and meningitis. The drug features a long half-life, sustained action, good tolerability, and can be administered via intravenous or intramuscular injection, making it widely applicable in clinical practice. In recent years, with increasing antibiotic resistance and the ongoing global burden of infectious diseases, the demand for ceftriaxone sodium in hospitals, community healthcare settings, and emergency infection control has grown steadily. Manufacturers have also optimized production processes and integrated raw materials to improve efficiency and product quality stability.In this report, we study the Ceftriaxone Sodium API.In 2024, global Ceftriaxone Sodium production reached approximately 2766 mt, with an average global market price of around US$ 94 per kg.

The global burden of infectious diseases continues to rise, particularly in developing countries and regions with aging populations, driving steady growth in demand for antibiotics and providing a strong growth impetus for the ceftriaxone sodium market. Governments are promoting policies for rational antibiotic use, insurance coverage, and updated clinical guidelines, encouraging hospitals to procure high-quality antibiotics. Annual reports indicate that leading pharmaceutical manufacturers continue to invest in raw material integration, capacity expansion, and development of new formulations to ensure supply stability and product diversity. Brokerage reports highlight that antimicrobial resistance control, community infection management, and standardized clinical usage trends will further increase market penetration of ceftriaxone sodium in hospitals and primary care facilities.

The ceftriaxone sodium industry faces challenges such as raw material price volatility, complex production processes, and strict international quality standards. Annual reports reveal that key raw materials are partially imported, and supply chain fluctuations may impact production stability. Antibiotic resistance issues, strengthened regulatory oversight, and centralized procurement or price caps may pressure mid- to low-end product margins. Cross-border market expansion must also navigate registration approvals, market access, and regulatory differences, increasing operational risks for enterprises.

Downstream demand from hospitals, community healthcare institutions, and public health departments shows stable growth with structural optimization. Clinicians prefer formulations suitable for long-term storage, flexible dosing regimens, and both intravenous and intramuscular administration to address different infection types and emergency scenarios. Brokerage reports indicate that with the promotion of rational antibiotic use, hospital medication standardization, and digital drug management systems, ceftriaxone sodium is expected to achieve higher clinical adherence and inventory efficiency, while high-end formulations and novel extended-release products may become key points of market differentiation in the future.

This report aims to provide a comprehensive presentation of the global market for Ceftriaxone Sodium, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ceftriaxone Sodium by region & country, by Type, and by Application.

The Ceftriaxone Sodium market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ceftriaxone Sodium.

Market Segmentation

By Company

  • Shandong Ruiying
  • Qilu Antibiotics
  • Nectar Lifesciences
  • Kelun
  • United Laboratories
  • Aurobindo Pharma
  • Orchid Pharma
  • Medya Pharma
  • REYOUNG
  • LKPC
  • ACS Dobfar
  • NCPC
  • Dawnrays
  • Kopran

Segment by Type

  • ChP
  • USP
  • EP

Segment by Application

  • Single Injection
  • Compound Injection

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Ceftriaxone Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Ceftriaxone Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Ceftriaxone Sodium in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Ceftriaxone Sodium Product Introduction
  • 1.2 Global Ceftriaxone Sodium Market Size Forecast
    • 1.2.1 Global Ceftriaxone Sodium Sales Value (2020-2031)
    • 1.2.2 Global Ceftriaxone Sodium Sales Volume (2020-2031)
    • 1.2.3 Global Ceftriaxone Sodium Sales Price (2020-2031)
  • 1.3 Ceftriaxone Sodium Market Trends & Drivers
    • 1.3.1 Ceftriaxone Sodium Industry Trends
    • 1.3.2 Ceftriaxone Sodium Market Drivers & Opportunity
    • 1.3.3 Ceftriaxone Sodium Market Challenges
    • 1.3.4 Ceftriaxone Sodium Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Ceftriaxone Sodium Players Revenue Ranking (2024)
  • 2.2 Global Ceftriaxone Sodium Revenue by Company (2020-2025)
  • 2.3 Global Ceftriaxone Sodium Players Sales Volume Ranking (2024)
  • 2.4 Global Ceftriaxone Sodium Sales Volume by Company Players (2020-2025)
  • 2.5 Global Ceftriaxone Sodium Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Ceftriaxone Sodium Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Ceftriaxone Sodium Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Ceftriaxone Sodium
  • 2.9 Ceftriaxone Sodium Market Competitive Analysis
    • 2.9.1 Ceftriaxone Sodium Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Ceftriaxone Sodium Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ceftriaxone Sodium as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 ChP
    • 3.1.2 USP
    • 3.1.3 EP
  • 3.2 Global Ceftriaxone Sodium Sales Value by Type
    • 3.2.1 Global Ceftriaxone Sodium Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Ceftriaxone Sodium Sales Value, by Type (2020-2031)
    • 3.2.3 Global Ceftriaxone Sodium Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Ceftriaxone Sodium Sales Volume by Type
    • 3.3.1 Global Ceftriaxone Sodium Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Ceftriaxone Sodium Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Ceftriaxone Sodium Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Ceftriaxone Sodium Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Single Injection
    • 4.1.2 Compound Injection
  • 4.2 Global Ceftriaxone Sodium Sales Value by Application
    • 4.2.1 Global Ceftriaxone Sodium Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Ceftriaxone Sodium Sales Value, by Application (2020-2031)
    • 4.2.3 Global Ceftriaxone Sodium Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Ceftriaxone Sodium Sales Volume by Application
    • 4.3.1 Global Ceftriaxone Sodium Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Ceftriaxone Sodium Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Ceftriaxone Sodium Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Ceftriaxone Sodium Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Ceftriaxone Sodium Sales Value by Region
    • 5.1.1 Global Ceftriaxone Sodium Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Ceftriaxone Sodium Sales Value by Region (2020-2025)
    • 5.1.3 Global Ceftriaxone Sodium Sales Value by Region (2026-2031)
    • 5.1.4 Global Ceftriaxone Sodium Sales Value by Region (%), (2020-2031)
  • 5.2 Global Ceftriaxone Sodium Sales Volume by Region
    • 5.2.1 Global Ceftriaxone Sodium Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Ceftriaxone Sodium Sales Volume by Region (2020-2025)
    • 5.2.3 Global Ceftriaxone Sodium Sales Volume by Region (2026-2031)
    • 5.2.4 Global Ceftriaxone Sodium Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Ceftriaxone Sodium Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Ceftriaxone Sodium Sales Value, 2020-2031
    • 5.4.2 North America Ceftriaxone Sodium Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Ceftriaxone Sodium Sales Value, 2020-2031
    • 5.5.2 Europe Ceftriaxone Sodium Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Ceftriaxone Sodium Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Ceftriaxone Sodium Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Ceftriaxone Sodium Sales Value, 2020-2031
    • 5.7.2 South America Ceftriaxone Sodium Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Ceftriaxone Sodium Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Ceftriaxone Sodium Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Ceftriaxone Sodium Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Ceftriaxone Sodium Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Ceftriaxone Sodium Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Ceftriaxone Sodium Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Ceftriaxone Sodium Sales Value, 2020-2031
    • 6.3.2 United States Ceftriaxone Sodium Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Ceftriaxone Sodium Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Ceftriaxone Sodium Sales Value, 2020-2031
    • 6.4.2 Europe Ceftriaxone Sodium Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Ceftriaxone Sodium Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Ceftriaxone Sodium Sales Value, 2020-2031
    • 6.5.2 China Ceftriaxone Sodium Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Ceftriaxone Sodium Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Ceftriaxone Sodium Sales Value, 2020-2031
    • 6.6.2 Japan Ceftriaxone Sodium Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Ceftriaxone Sodium Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Ceftriaxone Sodium Sales Value, 2020-2031
    • 6.7.2 South Korea Ceftriaxone Sodium Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Ceftriaxone Sodium Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Ceftriaxone Sodium Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Ceftriaxone Sodium Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Ceftriaxone Sodium Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Ceftriaxone Sodium Sales Value, 2020-2031
    • 6.9.2 India Ceftriaxone Sodium Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Ceftriaxone Sodium Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Shandong Ruiying
    • 7.1.1 Shandong Ruiying Company Information
    • 7.1.2 Shandong Ruiying Introduction and Business Overview
    • 7.1.3 Shandong Ruiying Ceftriaxone Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Shandong Ruiying Ceftriaxone Sodium Product Offerings
    • 7.1.5 Shandong Ruiying Recent Development
  • 7.2 Qilu Antibiotics
    • 7.2.1 Qilu Antibiotics Company Information
    • 7.2.2 Qilu Antibiotics Introduction and Business Overview
    • 7.2.3 Qilu Antibiotics Ceftriaxone Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Qilu Antibiotics Ceftriaxone Sodium Product Offerings
    • 7.2.5 Qilu Antibiotics Recent Development
  • 7.3 Nectar Lifesciences
    • 7.3.1 Nectar Lifesciences Company Information
    • 7.3.2 Nectar Lifesciences Introduction and Business Overview
    • 7.3.3 Nectar Lifesciences Ceftriaxone Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Nectar Lifesciences Ceftriaxone Sodium Product Offerings
    • 7.3.5 Nectar Lifesciences Recent Development
  • 7.4 Kelun
    • 7.4.1 Kelun Company Information
    • 7.4.2 Kelun Introduction and Business Overview
    • 7.4.3 Kelun Ceftriaxone Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Kelun Ceftriaxone Sodium Product Offerings
    • 7.4.5 Kelun Recent Development
  • 7.5 United Laboratories
    • 7.5.1 United Laboratories Company Information
    • 7.5.2 United Laboratories Introduction and Business Overview
    • 7.5.3 United Laboratories Ceftriaxone Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 United Laboratories Ceftriaxone Sodium Product Offerings
    • 7.5.5 United Laboratories Recent Development
  • 7.6 Aurobindo Pharma
    • 7.6.1 Aurobindo Pharma Company Information
    • 7.6.2 Aurobindo Pharma Introduction and Business Overview
    • 7.6.3 Aurobindo Pharma Ceftriaxone Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Aurobindo Pharma Ceftriaxone Sodium Product Offerings
    • 7.6.5 Aurobindo Pharma Recent Development
  • 7.7 Orchid Pharma
    • 7.7.1 Orchid Pharma Company Information
    • 7.7.2 Orchid Pharma Introduction and Business Overview
    • 7.7.3 Orchid Pharma Ceftriaxone Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Orchid Pharma Ceftriaxone Sodium Product Offerings
    • 7.7.5 Orchid Pharma Recent Development
  • 7.8 Medya Pharma
    • 7.8.1 Medya Pharma Company Information
    • 7.8.2 Medya Pharma Introduction and Business Overview
    • 7.8.3 Medya Pharma Ceftriaxone Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Medya Pharma Ceftriaxone Sodium Product Offerings
    • 7.8.5 Medya Pharma Recent Development
  • 7.9 REYOUNG
    • 7.9.1 REYOUNG Company Information
    • 7.9.2 REYOUNG Introduction and Business Overview
    • 7.9.3 REYOUNG Ceftriaxone Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 REYOUNG Ceftriaxone Sodium Product Offerings
    • 7.9.5 REYOUNG Recent Development
  • 7.10 LKPC
    • 7.10.1 LKPC Company Information
    • 7.10.2 LKPC Introduction and Business Overview
    • 7.10.3 LKPC Ceftriaxone Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 LKPC Ceftriaxone Sodium Product Offerings
    • 7.10.5 LKPC Recent Development
  • 7.11 ACS Dobfar
    • 7.11.1 ACS Dobfar Company Information
    • 7.11.2 ACS Dobfar Introduction and Business Overview
    • 7.11.3 ACS Dobfar Ceftriaxone Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 ACS Dobfar Ceftriaxone Sodium Product Offerings
    • 7.11.5 ACS Dobfar Recent Development
  • 7.12 NCPC
    • 7.12.1 NCPC Company Information
    • 7.12.2 NCPC Introduction and Business Overview
    • 7.12.3 NCPC Ceftriaxone Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 NCPC Ceftriaxone Sodium Product Offerings
    • 7.12.5 NCPC Recent Development
  • 7.13 Dawnrays
    • 7.13.1 Dawnrays Company Information
    • 7.13.2 Dawnrays Introduction and Business Overview
    • 7.13.3 Dawnrays Ceftriaxone Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.13.4 Dawnrays Ceftriaxone Sodium Product Offerings
    • 7.13.5 Dawnrays Recent Development
  • 7.14 Kopran
    • 7.14.1 Kopran Company Information
    • 7.14.2 Kopran Introduction and Business Overview
    • 7.14.3 Kopran Ceftriaxone Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.14.4 Kopran Ceftriaxone Sodium Product Offerings
    • 7.14.5 Kopran Recent Development

8 Industry Chain Analysis

  • 8.1 Ceftriaxone Sodium Industrial Chain
  • 8.2 Ceftriaxone Sodium Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Ceftriaxone Sodium Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Ceftriaxone Sodium Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Ceftriaxone Sodium Market Trends
  • Table 2. Ceftriaxone Sodium Market Drivers & Opportunity
  • Table 3. Ceftriaxone Sodium Market Challenges
  • Table 4. Ceftriaxone Sodium Market Restraints
  • Table 5. Global Ceftriaxone Sodium Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Ceftriaxone Sodium Revenue Market Share by Company (2020-2025)
  • Table 7. Global Ceftriaxone Sodium Sales Volume by Company (2020-2025) & (MT)
  • Table 8. Global Ceftriaxone Sodium Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Ceftriaxone Sodium Price by Company (2020-2025) & (USD/Kg)
  • Table 10. Key Manufacturers Ceftriaxone Sodium Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Ceftriaxone Sodium Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Ceftriaxone Sodium
  • Table 13. Global Ceftriaxone Sodium Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ceftriaxone Sodium as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Ceftriaxone Sodium Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Ceftriaxone Sodium Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Ceftriaxone Sodium Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Ceftriaxone Sodium Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Ceftriaxone Sodium Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Ceftriaxone Sodium Sales Volume by Type: 2020 VS 2024 VS 2031 (MT)
  • Table 22. Global Ceftriaxone Sodium Sales Volume by Type (2020-2025) & (MT)
  • Table 23. Global Ceftriaxone Sodium Sales Volume by Type (2026-2031) & (MT)
  • Table 24. Global Ceftriaxone Sodium Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Ceftriaxone Sodium Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Ceftriaxone Sodium Price by Type (2020-2025) & (USD/Kg)
  • Table 27. Global Ceftriaxone Sodium Price by Type (2026-2031) & (USD/Kg)
  • Table 28. Global Ceftriaxone Sodium Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Ceftriaxone Sodium Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Ceftriaxone Sodium Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Ceftriaxone Sodium Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Ceftriaxone Sodium Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Ceftriaxone Sodium Sales Volume by Application: 2020 VS 2024 VS 2031 (MT)
  • Table 34. Global Ceftriaxone Sodium Sales Volume by Application (2020-2025) & (MT)
  • Table 35. Global Ceftriaxone Sodium Sales Volume by Application (2026-2031) & (MT)
  • Table 36. Global Ceftriaxone Sodium Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Ceftriaxone Sodium Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Ceftriaxone Sodium Price by Application (2020-2025) & (USD/Kg)
  • Table 39. Global Ceftriaxone Sodium Price by Application (2026-2031) & (USD/Kg)
  • Table 40. Global Ceftriaxone Sodium Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Ceftriaxone Sodium Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Ceftriaxone Sodium Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Ceftriaxone Sodium Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Ceftriaxone Sodium Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Ceftriaxone Sodium Sales Volume by Region (MT): 2020 VS 2024 VS 2031
  • Table 46. Global Ceftriaxone Sodium Sales Volume by Region (2020-2025) & (MT)
  • Table 47. Global Ceftriaxone Sodium Sales Volume by Region (2026-2031) & (MT)
  • Table 48. Global Ceftriaxone Sodium Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Ceftriaxone Sodium Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Ceftriaxone Sodium Average Price by Region (2020-2025) & (USD/Kg)
  • Table 51. Global Ceftriaxone Sodium Average Price by Region (2026-2031) & (USD/Kg)
  • Table 52. Key Countries/Regions Ceftriaxone Sodium Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Ceftriaxone Sodium Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Ceftriaxone Sodium Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Ceftriaxone Sodium Sales Volume, (2020-2025) & (MT)
  • Table 56. Key Countries/Regions Ceftriaxone Sodium Sales Volume, (2026-2031) & (MT)
  • Table 57. Shandong Ruiying Company Information
  • Table 58. Shandong Ruiying Introduction and Business Overview
  • Table 59. Shandong Ruiying Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 60. Shandong Ruiying Ceftriaxone Sodium Product Offerings
  • Table 61. Shandong Ruiying Recent Development
  • Table 62. Qilu Antibiotics Company Information
  • Table 63. Qilu Antibiotics Introduction and Business Overview
  • Table 64. Qilu Antibiotics Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 65. Qilu Antibiotics Ceftriaxone Sodium Product Offerings
  • Table 66. Qilu Antibiotics Recent Development
  • Table 67. Nectar Lifesciences Company Information
  • Table 68. Nectar Lifesciences Introduction and Business Overview
  • Table 69. Nectar Lifesciences Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 70. Nectar Lifesciences Ceftriaxone Sodium Product Offerings
  • Table 71. Nectar Lifesciences Recent Development
  • Table 72. Kelun Company Information
  • Table 73. Kelun Introduction and Business Overview
  • Table 74. Kelun Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 75. Kelun Ceftriaxone Sodium Product Offerings
  • Table 76. Kelun Recent Development
  • Table 77. United Laboratories Company Information
  • Table 78. United Laboratories Introduction and Business Overview
  • Table 79. United Laboratories Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 80. United Laboratories Ceftriaxone Sodium Product Offerings
  • Table 81. United Laboratories Recent Development
  • Table 82. Aurobindo Pharma Company Information
  • Table 83. Aurobindo Pharma Introduction and Business Overview
  • Table 84. Aurobindo Pharma Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 85. Aurobindo Pharma Ceftriaxone Sodium Product Offerings
  • Table 86. Aurobindo Pharma Recent Development
  • Table 87. Orchid Pharma Company Information
  • Table 88. Orchid Pharma Introduction and Business Overview
  • Table 89. Orchid Pharma Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 90. Orchid Pharma Ceftriaxone Sodium Product Offerings
  • Table 91. Orchid Pharma Recent Development
  • Table 92. Medya Pharma Company Information
  • Table 93. Medya Pharma Introduction and Business Overview
  • Table 94. Medya Pharma Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 95. Medya Pharma Ceftriaxone Sodium Product Offerings
  • Table 96. Medya Pharma Recent Development
  • Table 97. REYOUNG Company Information
  • Table 98. REYOUNG Introduction and Business Overview
  • Table 99. REYOUNG Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 100. REYOUNG Ceftriaxone Sodium Product Offerings
  • Table 101. REYOUNG Recent Development
  • Table 102. LKPC Company Information
  • Table 103. LKPC Introduction and Business Overview
  • Table 104. LKPC Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 105. LKPC Ceftriaxone Sodium Product Offerings
  • Table 106. LKPC Recent Development
  • Table 107. ACS Dobfar Company Information
  • Table 108. ACS Dobfar Introduction and Business Overview
  • Table 109. ACS Dobfar Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 110. ACS Dobfar Ceftriaxone Sodium Product Offerings
  • Table 111. ACS Dobfar Recent Development
  • Table 112. NCPC Company Information
  • Table 113. NCPC Introduction and Business Overview
  • Table 114. NCPC Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 115. NCPC Ceftriaxone Sodium Product Offerings
  • Table 116. NCPC Recent Development
  • Table 117. Dawnrays Company Information
  • Table 118. Dawnrays Introduction and Business Overview
  • Table 119. Dawnrays Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 120. Dawnrays Ceftriaxone Sodium Product Offerings
  • Table 121. Dawnrays Recent Development
  • Table 122. Kopran Company Information
  • Table 123. Kopran Introduction and Business Overview
  • Table 124. Kopran Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 125. Kopran Ceftriaxone Sodium Product Offerings
  • Table 126. Kopran Recent Development
  • Table 127. Key Raw Materials Lists
  • Table 128. Raw Materials Key Suppliers Lists
  • Table 129. Ceftriaxone Sodium Downstream Customers
  • Table 130. Ceftriaxone Sodium Distributors List
  • Table 131. Research Programs/Design for This Report
  • Table 132. Key Data Information from Secondary Sources
  • Table 133. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Ceftriaxone Sodium Product Picture
  • Figure 2. Global Ceftriaxone Sodium Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Ceftriaxone Sodium Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Ceftriaxone Sodium Sales Volume (2020-2031) & (MT)
  • Figure 5. Global Ceftriaxone Sodium Sales Price (2020-2031) & (USD/Kg)
  • Figure 6. Ceftriaxone Sodium Report Years Considered
  • Figure 7. Global Ceftriaxone Sodium Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Ceftriaxone Sodium Players Sales Volume Ranking (2024) & (MT)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Ceftriaxone Sodium Revenue in 2024
  • Figure 10. Ceftriaxone Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. ChP Picture
  • Figure 12. USP Picture
  • Figure 13. EP Picture
  • Figure 14. Global Ceftriaxone Sodium Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 15. Global Ceftriaxone Sodium Sales Value Market Share by Type, 2024 & 2031
  • Figure 16. Global Ceftriaxone Sodium Sales Volume by Type (2020 VS 2024 VS 2031) & (MT)
  • Figure 17. Global Ceftriaxone Sodium Sales Volume Market Share by Type, 2024 & 2031
  • Figure 18. Global Ceftriaxone Sodium Price by Type (2020-2031) & (USD/Kg)
  • Figure 19. Product Picture of Single Injection
  • Figure 20. Product Picture of Compound Injection
  • Figure 21. Global Ceftriaxone Sodium Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global Ceftriaxone Sodium Sales Value Market Share by Application, 2024 & 2031
  • Figure 23. Global Ceftriaxone Sodium Sales Volume by Application (2020 VS 2024 VS 2031) & (MT)
  • Figure 24. Global Ceftriaxone Sodium Sales Volume Market Share by Application, 2024 & 2031
  • Figure 25. Global Ceftriaxone Sodium Price by Application (2020-2031) & (USD/Kg)
  • Figure 26. North America Ceftriaxone Sodium Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America Ceftriaxone Sodium Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe Ceftriaxone Sodium Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe Ceftriaxone Sodium Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific Ceftriaxone Sodium Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific Ceftriaxone Sodium Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America Ceftriaxone Sodium Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America Ceftriaxone Sodium Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa Ceftriaxone Sodium Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa Ceftriaxone Sodium Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions Ceftriaxone Sodium Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions Ceftriaxone Sodium Sales Volume (%), (2020-2031)
  • Figure 38. United States Ceftriaxone Sodium Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Ceftriaxone Sodium Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Ceftriaxone Sodium Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Europe Ceftriaxone Sodium Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Ceftriaxone Sodium Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Ceftriaxone Sodium Sales Value by Application (%), 2024 VS 2031
  • Figure 44. China Ceftriaxone Sodium Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Ceftriaxone Sodium Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Ceftriaxone Sodium Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Japan Ceftriaxone Sodium Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Ceftriaxone Sodium Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Ceftriaxone Sodium Sales Value by Application (%), 2024 VS 2031
  • Figure 50. South Korea Ceftriaxone Sodium Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Ceftriaxone Sodium Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Ceftriaxone Sodium Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Southeast Asia Ceftriaxone Sodium Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Ceftriaxone Sodium Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Ceftriaxone Sodium Sales Value by Application (%), 2024 VS 2031
  • Figure 56. India Ceftriaxone Sodium Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Ceftriaxone Sodium Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Ceftriaxone Sodium Sales Value by Application (%), 2024 VS 2031
  • Figure 59. Ceftriaxone Sodium Industrial Chain
  • Figure 60. Ceftriaxone Sodium Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed